K.C. Pharmaceuticals, Inc. has recalled approximately 738,998 bottles of various eye drops, including Original Redness Reliever (tetrahydrozoline HCl) and Dry Eye Relief Lubricant (glycerin, hypromellose, and polyethylene glycol). The recall was issued due to manufacturing deficiencies and a lack of proper documentation regarding the product filling line, which could affect the sterility and quality of the drops. These products were sold under numerous brand names including equate, DG health, CVS Health, Walgreens, and meijer at retail stores nationwide.
Deficiencies in the manufacturing process for sterile eye products can lead to potential contamination. Using non-sterile eye drops can cause serious eye infections, which may lead to vision impairment or other eye health complications.
You have 2 options:
Distributed under various store brands including DG health, Publix, sunmark, TopCare, GoodSense, Circle K, Lil Drug Store, Rugby, Leader, CAREone, Good Neighbor, Walgreens, CVS, H-E-B, meijer, and Best Choice.
Distributed under various store brands including equate, DG health, sunmark, TopCare, HealthMart, exchange select, meijer, H-E-B, and GeriCare.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.